The SEC recently confirmed that the new CEO pay ratio disclosure rules mandated in the Dodd-Frank Act will go into effect in the 2018 proxy season. To assist companies in preparation of the new disclosure, the SEC published interpretive guidance on September 21, 2017.
SEC Publishes Helpful Guidance on Pay Ratio Disclosure
By Mark J. Mihanovic, Robert H. Cohen, Thomas P. Conaghan, Thomas J. Murphy, Andrew Liazos, Eric Orsic, Gary Emmanuel and Heidi J. Steele on October 26, 2017
Posted In Benefit Controversies, Executive Compensation
Tags: CEO pay ratio, CEO pay ratio disclosure rules, Commission Guidance, Compliance and Disclosure Interpretations, Consumer Protection Act of 2010, disclosure requirement, Dodd-Frank Act, Dodd-Frank Wall Street Reform, Employee Determinations, Item 402(u), median employee, Median Employee Determinations, Methodologies, proxy season, Staff Guidance, The Staff of the Division of Corporation Finance, US Securities and Exchange Commission (SEC), W-2
Mark J. MihanovicMark J. Mihanovic, head of the Firm’s California Corporate group and head of the Firm's Emerging Companies/Venture Capital group, focuses his practice primarily in the areas of corporate finance and mergers and acquisitions. He represents companies in a broad range of industries, with a particular emphasis on technology, life science and health care companies. Mark serves as corporate liaison partner in the Firm’s strategic alliance with MWE China Law Offices based in Shanghai. Read Mark Mihanovic's full bio.
Robert H. CohenRobert (Bob) H. Cohen focuses his practice on transactional and securities work for a broad range of clients. He counsels clients on initial and follow-on public offerings, special-purpose acquisition (SPAC), at-the-market (ATM) and off the shelf offerings, registered direct and private investment in public equity (PIPE) financings, private placements, bridge financings and equity lines, and related transactions. Bob also has extensive experience in the areas of mergers and acquisitions, joint ventures, 1933 and 1934 representation, and licensing and distribution arrangements. Read Robert Cohen's full bio.
Thomas P. ConaghanThomas (Tom) P. Conaghan represents public and private companies, underwriters and other sources of capital, corporate boards and board committees, and corporate executives. He advises US- and foreign-based public companies on issues relating to mergers and acquisitions (M&A), joint ventures, strategic investments, spin-offs, public and private offerings of securities (including initial public offerings (IPOs)), disclosure, Securities and Exchange Commission (SEC) reporting, corporate governance, executive compensation, and the stock exchange-listed company rules. Tom is co-head of the Firm's Capital Markets and Public Companies Group, and partner-in-charge of the Corporate Group in the Firm's Washington, DC office. Read Tom Conaghan's full bio.
Thomas J. Murphy
Andrew LiazosAndrew C. Liazos is the global chair of McDermott’s Benefits & Compensation Practice Group and has practiced at McDermott for over 25 years. Andrew focuses his practice on compensation and benefit matters, including related securities, M&A, IPO, private equity, international and litigation matters. Clients range from Fortune 500 companies to compensation committees to individual executives in employment and severance negotiations. Read Andrew Liazos' full bio.
Eric OrsicEric Orsic is the co-head of the Firm’s Capital Markets and Public Companies Practice Group. Eric advises clients in the areas of mergers and acquisitions, and securities transactions and compliance. He works with publicly and privately held companies to structure and negotiate business acquisitions/dispositions. His public company transactional experience includes public equity and debt offerings, tender offers and going-private transactions. Read Eric Orsic's full bio.
Gary EmmanuelGary Emmanuel focuses his practice on corporate securities matters. With over 15 years of experience, Gary represents both domestic and foreign companies that are navigating the process of capital raising, including initial public offerings, registered direct offerings, follow-on offerings, private placements, private investment in public equities (PIPEs) and bridge financings. Gary has worked extensively with biotechnology and other life science companies, both as company counsel and as underwriter's counsel. Read Gary Emmanuel's full bio.
Heidi J. SteeleHeidi J. Steele Focuses her practice on corporate securities, mergers and acquisitions of public and private companies and corporate counseling. She has extensive experience in public and private equity and debt financings, compliance with disclosure and regulatory requirements, tender offers and mergers, acquisitions and dispositions. She advises public and private corporations on a variety of matters, including securities compliance. Read Heidi Steele's full bio.
Related Posts
- SEC Proposal on New Pay versus Performance Disclosure Rules
- A Light in the Dark: Seventh Circuit Helps Clarify New Pleading Standards for 401(k) Fee Cases
- SEC Adopts Final Pay Versus Performance Rules
- Understanding a Trustee’s Role in Management Incentive Plans
- Employers Explore Abortion Coverage Continuation
BLOG EDITORS
STAY CONNECTED
TOPICS
ARCHIVES
RECENT POSTS
- HHS Letter Reiterates Expectations for Language Accessibility
- Employee Benefit Plans: Important Considerations for Year-End and 2025
- Post-Election Outlook: Issues to Watch for Pharmacy Industry Stakeholders
- Post-Election Health Policy Priorities
- IRS Issues Proposed Regulations to Ensure Expanded Preventative Care Services Coverage
